Shares of Dr. Martens plc (LON:DOCS - Get Free Report) traded up 0.7% on Thursday . The stock traded as high as GBX 60 ($0.81) and last traded at GBX 59.95 ($0.81). 1,098,886 shares changed hands during mid-day trading, a decline of 50% from the average session volume of 2,196,119 shares. The stock had previously closed at GBX 59.55 ($0.81).
Wall Street Analysts Forecast Growth
Separately, Royal Bank of Canada lowered their target price on shares of Dr. Martens from GBX 7,000 ($95.06) to GBX 6,000 ($81.48) and set a "sector perform" rating for the company in a research note on Monday, May 19th.
Get Our Latest Analysis on DOCS
Dr. Martens Stock Up 25.8%
The stock has a market cap of £731.96 million, a price-to-earnings ratio of 10.69, a PEG ratio of 6.40 and a beta of 0.11. The company has a quick ratio of 1.13, a current ratio of 2.85 and a debt-to-equity ratio of 127.27. The stock has a fifty day moving average of GBX 54.24 and a two-hundred day moving average of GBX 62.52.
Dr. Martens (LON:DOCS - Get Free Report) last posted its earnings results on Thursday, June 5th. The company reported GBX 2.40 ($0.03) earnings per share (EPS) for the quarter. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%. As a group, analysts predict that Dr. Martens plc will post 2.5809394 EPS for the current fiscal year.
Dr. Martens Cuts Dividend
The business also recently disclosed a dividend, which was paid on Tuesday, April 8th. Shareholders of record on Thursday, March 6th were paid a dividend of GBX 0.85 ($0.01) per share. The ex-dividend date of this dividend was Thursday, March 6th. This represents a yield of 1.47%. Dr. Martens's dividend payout ratio (DPR) is 42.53%.
Insider Transactions at Dr. Martens
In other news, insider Giles Wilson purchased 32,640 shares of the company's stock in a transaction on Tuesday, March 25th. The shares were bought at an average price of GBX 54 ($0.73) per share, for a total transaction of £17,625.60 ($23,934.82). Over the last 90 days, insiders have purchased 33,206 shares of company stock valued at $1,792,771. Insiders own 4.36% of the company's stock.
About Dr. Martens
(
Get Free Report)
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Read More
Before you consider Dr. Martens, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dr. Martens wasn't on the list.
While Dr. Martens currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
